1 Shields Ave., 174 Briggs Hall, Univ. of California, Davis, CA 95616, USA.
J Appl Physiol (1985). 2011 Feb;110(2):561-8. doi: 10.1152/japplphysiol.00941.2010. Epub 2010 Nov 11.
For over 10 years, we have known that the activation of the mammalian target of rapamycin complex 1 (mTORC1) has correlated with the increase in skeletal muscle size and strength that occurs following resistance exercise. Initial cell culture and rodent models of muscle growth demonstrated that the activation of mTORC1 is common to hypertrophy induced by growth factors and increased loading. The further observation that high loads increased the local production of growth factors led to the paradigm that resistance exercise stimulates the autocrine production of factors that act on membrane receptors to activate mTORC1, and this results in skeletal muscle hypertrophy. Over the last few years, there has been a paradigm shift. From both human and rodent studies, it has become clear that the phenotypic and molecular responses to resistance exercise occur in a growth factor-independent manner. Although the mechanism of load-induced mTORC1 activation remains to be determined, it is clear that it does not require classical growth factor signaling.
十年来,我们已经知道哺乳动物雷帕霉素靶蛋白复合物 1(mTORC1)的激活与抗阻运动后骨骼肌体积和力量的增加有关。最初的细胞培养和肌肉生长的啮齿动物模型表明,mTORC1 的激活是由生长因子诱导的和增加的负荷诱导的肥大所共有的。进一步观察到高负荷增加了生长因子的局部产生,导致了这样一种观点,即抗阻运动刺激了因子的自分泌产生,这些因子作用于膜受体以激活 mTORC1,从而导致骨骼肌肥大。在过去的几年中,这种模式发生了转变。无论是从人类还是啮齿动物的研究中,都已经清楚地表明,抗阻运动的表型和分子反应是独立于生长因子的。虽然负荷诱导的 mTORC1 激活的机制仍有待确定,但很明显,它不需要经典的生长因子信号。